You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,399,638


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,399,638
Title:Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
Abstract: Provided herein are isolated genomic polynucleotide fragments from the p15 arm of chromosome 11 and methods of use.
Inventor(s): Ryan; James (Augusta, GA)
Assignee: Ryogen LLC (Suffern, NY)
Application Number:13/235,404
Patent Claims:1. An isolated polynucleotide which is at least 99% identical to (a) the polynucleotide shown in SEQ ID NO: 11; (b) a polynucleotide fragment of (a) comprising at least nucleotides 10471-29787 of SEQ ID NO:11, wherein (a)-(b) encode a polypeptide which is at least 99% identical to SEQ ID NO:5 and has human cluster of differentiation antigen 81 activity or (c): a reverse strand of the polynucleotides of (a) or (b).

2. A nucleic acid construct comprising the polynucleotide of claim 1.

3. An expression vector comprising the polynucleotide of claim 1.

4. A recombinant host cell comprising the polynucleotide of claim 1.

5. A method for obtaining human cluster of differentiation antigen 81 comprising: (a) culturing the recombinant host cell of claim 4 under conditions that provide for obtaining human cluster of differentiation antigen 81 and (b) recovering said human cluster of differentiation antigen 81.

6. An isolated polynucleotide at least 50 nucleotides in length identical to a region of SEQ ID NO: 11, said region selected from the group consisting of a 5'-noncoding region consisting of nucleotides 1-10235 of SEQ ID NO: 11, and a 3'-non-coding region consisting of nucleotides 30341-37113 of SEQ ID NO:11 or reverse strand of said isolated polynucleotide.

7. The isolated polynucleotide of claim 6, wherein said isolated polynucleotide comprises a dinucleotide selected from the group consisting of dinucleotides 10233-10234, 10537-10538, 23331-23332, 23447-23448, 27013-27014, 27114-27115, 27891-27892, 27965-27966, 28332-28333, 28442-28443, 28788-28789, 28892-28893, 29547-29548, 29636-29637 and 30341-30342 of SEQ ID NO:11.

8. An isolated polynucleotide obtainable from the p15 region of human chromosome 11 consisting of a nucleotide sequence selected from the group consisting of nucleotides 1-6186, 6187-12372, 24746-30931 and 30932-37113 of SEQ ID NO:11.

9. An isolated polynucleotide consisting of at least a 600 nucleotide fragment of the polynucleotide of claim 8.

10. A composition comprising the polynucleotide of claim 1 and a carrier or diluent.

11. A composition comprising the polynucleotide of claim 6 and a carrier or diluent.

12. A composition comprising the polynucleotide of claim 8 and a carrier or diluent.

13. A kit comprising the polynucleotide of claim 1.

14. A kit comprising the polynucleotide of claim 6.

15. A kit comprising the polynucleotide of claim 8.

16. A method of detecting the presence or absence of a variant of human cluster of differentiation antigen 81 in a sample using the polynucleotide of claim 1.

17. A method for obtaining the polynucleotide of claim 1 comprising (a) isolating genomic polynucleotide from a subject; (b) providing primers, probes and optionally polymerase, wherein said probes or primers are at least 50 nucleotides in length identical to a region of SEQ ID NO: 11, said region selected from the group consisting of a 5'-noncoding region consisting of nucleotides 1-10235 of SEQ ID NO: 11, and a 3'-non-coding region consisting of nucleotides 30341-37113 of SEQ ID NO: 11 or reverse strand of said regions and (c) incubating (a) and (b) under conditions promoting the isolation of said polynucleotide.

18. A method for obtaining a polynucleotide consisting of a 5'-noncoding, 3'-noncoding or intron fragment of SEQ ID NO: 11 or its complementary sequence comprising (a) isolating genomic polynucleotide from a subject; (b) providing primers, probes and optionally polymerase, wherein said probes or primers are at least 50 nucleotides in length identical to a region of SEQ ID NO: 11, said region selected from the group consisting of a 5'-noncoding region consisting of nucleotides 1-10235 of SEQ ID NO: 11, and a 3'-non-coding region consisting of nucleotides 30341-37113 of SEQ ID NO: 11 or reverse strand of said regions and (c) incubating (a) and (b) under conditions promoting the isolation of said polynucleotide.

19. The polynucleotide according to claim 1, wherein said polynucleotide is DNA or RNA.

20. The polynucleotide according to claim 6, wherein said polynucleotide is DNA or RNA.

21. The polynucleotide according to claim 8, wherein said polynucleotide is DNA or RNA.

22. The method according to claim 17, wherein said polynucleotide is DNA or RNA.

23. The method according to claim 18, wherein said polynucleotide is DNA or RNA.

Details for Patent 8,399,638

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2020-10-31
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2020-10-31
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2020-10-31
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.